168 related articles for article (PubMed ID: 19327601)
1. Hypercholesterolaemia and risk of coronary heart disease in the elderly: impact of age: the Copenhagen City Heart Study.
Iversen A; Jensen JS; Scharling H; Schnohr P
Eur J Intern Med; 2009 Mar; 20(2):139-44. PubMed ID: 19327601
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis.
Anum EA; Adera T
Ann Epidemiol; 2004 Oct; 14(9):705-21. PubMed ID: 15380802
[TBL] [Abstract][Full Text] [Related]
3. Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
Lloyd-Jones DM; Wilson PW; Larson MG; Leip E; Beiser A; D'Agostino RB; Cleeman JI; Levy D
Arch Intern Med; 2003 Sep; 163(16):1966-72. PubMed ID: 12963571
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
6. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
[TBL] [Abstract][Full Text] [Related]
7. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.
Langsted A; Freiberg JJ; Tybjaerg-Hansen A; Schnohr P; Jensen GB; Nordestgaard BG
J Intern Med; 2011 Jul; 270(1):65-75. PubMed ID: 21198993
[TBL] [Abstract][Full Text] [Related]
8. High total cholesterol levels in late life associated with a reduced risk of dementia.
Mielke MM; Zandi PP; Sjögren M; Gustafson D; Ostling S; Steen B; Skoog I
Neurology; 2005 May; 64(10):1689-95. PubMed ID: 15911792
[TBL] [Abstract][Full Text] [Related]
9. Trends in coronary heart disease risk factors in Auckland 1982-94.
Jackson R; Yee RL; Priest P; Shaw L; Beaglehole R
N Z Med J; 1995 Nov; 108(1011):451-4. PubMed ID: 8538961
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
[TBL] [Abstract][Full Text] [Related]
11. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
Miller M; Zhan M; Havas S
Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
Holst AG; Jensen G; Prescott E
Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
[TBL] [Abstract][Full Text] [Related]
15. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
[TBL] [Abstract][Full Text] [Related]
16. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
17. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly.
Mazza A; Tikhonoff V; Schiavon L; Casiglia E
Intern Med J; 2005 Oct; 35(10):604-10. PubMed ID: 16207260
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.
Connelly PW; MacLean DR; Horlick L; O'Connor B; Petrasovits A; Little JA
CMAJ; 1992 Jun; 146(11):1977-87. PubMed ID: 1596847
[TBL] [Abstract][Full Text] [Related]
19. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study.
Wong TY; Kamineni A; Klein R; Sharrett AR; Klein BE; Siscovick DS; Cushman M; Duncan BB
Arch Intern Med; 2006 Nov; 166(21):2388-94. PubMed ID: 17130394
[TBL] [Abstract][Full Text] [Related]
20. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
